Atlas Trials

A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies

Clinical trial NCT01476657 · TERMINATED

Trial details

NCT number
NCT01476657
Sponsor
SecuraBio
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2011-10-01
Primary completion
2016-12-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.